Menu
Integra LifeSciences is a global leader in regenerative tissue technologies and neurosurgical solutions dedicated to limiting uncertainty for clinicians, so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Bactiseal®, CerebroFlo®, Certas® Plus, Codman®, CUSA®, DuraGen®, DuraSeal®, ICP Express®, Integra®, MatriStem UBMTM, MediHoney®, MicroFrance®, PriMatrix®, SurgiMend®, TCC-EZ®, and VersaTru®.
1100 Campus Road
Princeton, New Jersey 08540
Phone: 16092750500
www.integralife.com
ClearBridge Investments, an investment management company, released its “ClearBridge SMID Cap Growth Strategy” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, the strategy outperformed the Russell 2500 Growth benchmark. On an absolute basis, the strategy gained in nine of the 10 sectors it was invested in […]
Integra''s fourth quarter results were in-line but still lackluster, with just 3% organic revenue growth. Click here to see our take on IART stock.
https://www.investing.com/news/pro/integra-lifesciences-pt-raised-to-55-at-piper-sandler-432SI-3011819
https://www.investing.com/news/assorted/integra-lifesciences-files-mixed-shelf-432SI-3011373
Integra LifeSciences Holdings Corporation (NASDAQ:NASDAQ:IART) Q4 2022 Earnings Conference Call February 22, 2023 8:30 AM ETCompany ParticipantsChris Ward - Senior Director, Investor…
The following slide deck was published by Integra LifeSciences Holdings Corporation in conjunction with their 2022 Q4 earnings call.
PRINCETON, N.J. (AP) — PRINCETON, N.J. (AP) — Integra LifeSciences Holdings Corp. (IART) on Wednesday reported fourth-quarter net income of…
PRINCETON, N.J., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, …
Integra LifeSciences Holdings press release (IART): Q4 Non-GAAP EPS of $0.94 beats by $0.04.Revenue of $398M (-1.8% Y/Y) misses by $0.57M.Outlook: For the full-year 2023, the…
PRINCETON, N.J., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2022, consistent with its preliminary financial results announced on January 10, 2023 and January 25, 2023.
Integra LifeSciences Holdings (IART) is scheduled to announce Q4 earnings results on Wednesday, February 22nd, before market open.The consensus EPS Estimate is $0.90 (+7.1% Y/Y) and…
PRINCETON, N.J., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter 2022 financial results on Wednesday, February 22, 2023, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET.
Integra LifeSciences (IART) has entered into an accelerated share repurchase agreement with Goldman Sachs.The agreement enables the firm to buyback $150M of its outstanding shares of…
